Literature DB >> 23656849

Residual symptoms in major depressive disorder: prevalence, effects, and management.

John Zajecka1, Susan G Kornstein, Pierre Blier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23656849     DOI: 10.4088/JCP.12059ah1

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  14 in total

1.  Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2014-07-21

2.  Potential long-term effects of a mind-body intervention for women with major depressive disorder: sustained mental health improvements with a pilot yoga intervention.

Authors:  Patricia Anne Kinser; R K Elswick; Susan Kornstein
Journal:  Arch Psychiatr Nurs       Date:  2014-09-03       Impact factor: 2.218

3.  Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms: A Randomized Clinical Trial.

Authors:  Zindel V Segal; Sona Dimidjian; Arne Beck; Jennifer M Boggs; Rachel Vanderkruik; Christina A Metcalf; Robert Gallop; Jennifer N Felder; Joseph Levy
Journal:  JAMA Psychiatry       Date:  2020-06-01       Impact factor: 21.596

4.  Web-based Mindfulness-based Cognitive Therapy for reducing residual depressive symptoms: An open trial and quasi-experimental comparison to propensity score matched controls.

Authors:  Sona Dimidjian; Arne Beck; Jennifer N Felder; Jennifer M Boggs; Robert Gallop; Zindel V Segal
Journal:  Behav Res Ther       Date:  2014-09-18

Review 5.  Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.

Authors:  Zindel V Segal; Kathleen M Walsh
Journal:  Curr Opin Psychiatry       Date:  2016-01       Impact factor: 4.741

6.  Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2).

Authors:  Louis S Matza; Lindsey T Murray; Glenn A Phillips; Thomas J Konechnik; Ellen B Dennehy; Elizabeth N Bush; Dennis A Revicki
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

7.  A conceptual framework of stress vulnerability, depression, and health outcomes in women: potential uses in research on complementary therapies for depression.

Authors:  Patricia A Kinser; Debra E Lyon
Journal:  Brain Behav       Date:  2014-07-10       Impact factor: 2.708

8.  The impact of residual symptoms on relapse and quality of life among Thai depressive patients.

Authors:  Thanita Hiranyatheb; Daochompu Nakawiro; Tinakon Wongpakaran; Nahathai Wongpakaran; Putipong Bookkamana; Manee Pinyopornpanish; Nattha Saisavoey; Kamonporn Wannarit; Sirina Satthapisit; Sitthinant Tanchakvaranont
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-12       Impact factor: 2.570

9.  What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment.

Authors:  Susan Ball; Peter Classi; Ellen B Dennehy
Journal:  Ann Gen Psychiatry       Date:  2014-03-19       Impact factor: 3.455

10.  Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study.

Authors:  Delphine Saragoussi; Maëlys Touya; Josep Maria Haro; Bengt Jönsson; Martin Knapp; Bastien Botrel; Ioana Florea; Henrik Loft; Benoît Rive
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.